Results 241 to 250 of about 717,561 (312)
Minimal residual disease (MRD) leads to cancer relapse and poor survival in ovarian cancer. The lack of representative 3D models limits therapy development. The microfluidics‐based high throughput 3D microtumor platform described here generates clinically‐relevant MRD models. The 3D microtumors recapitulate the molecular signatures of MRD from patients.
Xingyun Yang+14 more
wiley +1 more source
The international Human Genome Project (HGP) and China's contribution. [PDF]
Wang X, Xia Z, Chen C, Yang H.
europepmc +1 more source
The Environmental Genome Project: Ethical, Legal, and Social Implications
Richard R. Sharp, J. Carl Barrett
openalex +1 more source
Harnessing Nanohybridized Niclosamide for Precision Mpox Therapeutics
This study investigates the potential of nanohybridized niclosamide as a therapeutic agent for Mpox, focusing on enhanced bioavailability, improved antiviral efficacy, and controlled drug release achieved through nanoengineering. The research emphasizes significant advancements in formulation strategies, mechanistic insights, and therapeutic outcomes ...
N. Sanoj Rejinold+2 more
wiley +1 more source
The Personal Genome Project-UK, an open access resource of human multi-omics data. [PDF]
Chervova O+12 more
europepmc +1 more source
Negative‐ and positive‐staining TEM is essential for rapid nanometer‐resolution characterization of organic specimens ranging from nanoparticles to cells. Uranyl salts are widely used negative‐/positive‐stains but are radioactive and highly toxic to users and the environment.
Vera M. Kissling+4 more
wiley +1 more source
The Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer [PDF]
Robert L. Strausberg
openalex +1 more source